After the devastating earthquake, Lupin employees do come in full attendance for work as stated by Lupin president, Mr. Vinod. Lupin is one of the largest generic players in the neurology segment, with over 335 personnel at Kyowa. Apart from medicines, The Company would also be donating Yen 10 million to the Japanese Red Cross. The Japanese subsidiary of Zydus was damaged at the office; few of them have lost their homes as reported by Mr Ganesh Nayak, Chief Operating Officer and Executive Director. The joint venture of Japan with Dishman Pharma holds 85 per cent equity. The Ranbaxy partner stakeholders Daiichi Sankyo has been greatly affected by the earthquake. The Onahama plant and the Hiratsuka plant are highly damaged by the earthquake. The work has already begin to restart and will soon Meanwhile, work has already begun to restore operations announce any repercussions on Group sales affected by the disaster and the blackouts with due diligence as necessary. The branches at the outskirts have all resumed their work. The pharma company Daiichi Sankyo has also announced a donation of 100 million Japanese yen through the Japanese Red Cross.